LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication
Xiaonan Sheng(Shanghai Jiao Tong University), Jinsong Lu(Renji Hospital), Fan Yang(First People's Hospital of Yunnan Province), Wenjin Yin(Shanghai Jiao Tong University), Shuguang Xu(Renji Hospital), Liheng Zhou(Shanghai Jiao Tong University), Rui Sha(Wannan Medical College), Jing Peng(Shanghai Jiao Tong University), Yifan Wu(Shanghai Jiao Tong University), Yanping Lin(Shanghai Jiao Tong University), Huijuan Dai(Renji Hospital), Yueyao Du(Shanghai Jiao Tong University)
Cited by 39
Related Papers
Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week
|Nature Communications|2021|261
Harnessing copper-palladium alloy tetrapod nanoparticle-induced pro-survival autophagy for optimized photothermal therapy of drug-resistant cancer
|Nature Communications|2018|209
Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy
|EBioMedicine|2021|152
Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the Global Burden of Disease Study 2021
|Biomarker Research|2024|127
RNA-Activated CRISPR/Cas12a Nanorobots Operating in Living Cells
|Journal of the American Chemical Society|2024|84